当前位置: 首页 > 期刊 > 《中外医疗》 > 2013年第5期
编号:13171607
粪便隐血化学检测和免疫检测对于筛选结直肠癌的价值分析(2)
http://www.100md.com 2013年2月15日 《中外医疗》 2013年第5期
     [2] Hewitson P, Glasziou P, Watson E,et al. Co -chrane systematic review of colorectal cancer screening us-ing the fecal occult blood test (hemoccult): an update[J].Am J Gastroenterol,2008,103:1541-1549.

    [3] Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colo-rectal neoplasm: sensitivity, specificity, and predictive value: long-term fol-low-up in a large group practice setting[J].Ann Intern Med,1990,112:328-333.

    [4] Heitman SJ, Hilsden RJ, Au F, et al. Colorectal cancer screening for average-risk North Americans:an economic evaluation[J].PLoS Med,2010, 7(11):e1000370.

    [5] Liebeman DA,Weiss DG, Veterans Affairs Cooperative Study Group 380. One-time screening for colrectal cancer with combined fecal occult-blood testing and examination of the distal colon[J].N Engl J Med, 2001, 345(8):555-560.

    [6] 吴鹏,李艳,陈进,等. 联合免疫法和化学法检测粪便隐血的临床应用评价[J].检验医学,2010,25(3):176-178.

    [7] 杨明,丛玉隆,章子其,等. 转铁蛋白与血红蛋白同时检测消化道出血[J].临床检验杂志,2003,21(2):83-85.

    [8] 黄海深,成敬锋,陈国强,等.粪便隐血联合免疫法检测大肠癌的价值[J].现代医院,2009,9(8):69-70.

    (收稿日期:2012-12-24), 百拇医药(王华 宋予娟 魏巍)
上一页1 2